LigoCyte is a clinical-stage biologic drug development company focused on respiratory and gastrointestinal indications.
Business Model:
Revenue: $16M
Employees: 51-200
Ligocyte Pharma was acquired by
Takeda.
The acquisition happend on 2012-10-05.
Details of the transaction were not public
Address: 2155 Analysis Dr
City: Bozeman
State: MT
Zip: 59718
Country: US
LigoCyte is a clinical-stage biologic drug development company focused on respiratory and gastrointestinal indications.
Contact Phone:
+14065852733
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2010 | Debt Financing | $6.6M | 6/2012 | Venture Round | $2M | 6/2011 | Debt Financing | $5.5M | 1/2008 | Venture Round | 1 | - |
Eight Roads Ventures Eight Roads Ventures |
3/2008 | Series C | 5 | $29.5M |
Athenian Venture Partners Forward Ventures JAFCO MedImmune Ventures Novartis Venture Fund Athenian Venture Partners Forward Ventures JAFCO MedImmune Ventures Novartis Venture Fund |
1/2008 | Venture Round | 1 | - |
Eight Roads Ventures Eight Roads Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|